Cost-Effectiveness Of Dabigatran Compared With Warfarin, Apixaban, Rivaroxaban And Low Molecular Weight Heparins For The Treatment And Secondary Prevention Of Venous Thromboembolism In Colombia

Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.1423
https://www.valueinhealthjournal.com/article/S1098-3015(14)03353-1/fulltext
Title : Cost-Effectiveness Of Dabigatran Compared With Warfarin, Apixaban, Rivaroxaban And Low Molecular Weight Heparins For The Treatment And Secondary Prevention Of Venous Thromboembolism In Colombia
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)03353-1&doi=10.1016/j.jval.2014.08.1423
First page : A486
Section Title : Disease-Specific Studies
Open access? : No
Section Order : 910
Categories :
Tags :
Regions :
ViH Article Tags :